Lu L, Mullins CS, Schafmayer C, Zeissig S, Linnebacher M. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors. Cancer Commun (Lond). 2021;41(11):1137–51.

Article  PubMed  Google Scholar 

Yang Y, Liu L, Tian Y, Gu M, Wang Y, Ashrafizadeh M, et al. Autophagy-driven regulation of cisplatin response in human cancers: exploring molecular and cell death dynamics. Cancer Lett. 2024;587: 216659.

Article  CAS  PubMed  Google Scholar 

Bie B, Sun J, Guo Y, Li J, Jiang W, Yang J, et al. Baicalein: a review of its anti-cancer effects and mechanisms in Hepatocellular Carcinoma. Biomed Pharmacother. 2017;93:1285–91.

Article  CAS  PubMed  Google Scholar 

Liu H, Dong Y, Gao Y, Du Z, Wang Y, Cheng P, et al. The fascinating effects of Baicalein on cancer: a review. Int J Mol Sci. 2016;17(10).

Das TP, Suman S, Papu John AM, Pal D, Edwards A, Alatassi H, et al. Activation of AKT negatively regulates the pro-apoptotic function of death-associated protein kinase 3 (DAPK3) in prostate cancer. Cancer Lett. 2016;377(2):134–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Limbach KE, Wen W, Xing Q, Yan J, Yim JH. Baicalein activates 5’ adenosine monophosphate-activated protein kinase, inhibits the mammalian target of rapamycin, and exhibits antiproliferative effects in pancreatic neuroendocrine tumors in vitro and in vivo. Surgery. 2023;173(1):12–8.

Article  PubMed  Google Scholar 

Qin Y, Ashrafizadeh M, Mongiardini V, Grimaldi B, Crea F, Rietdorf K, et al. Autophagy and cancer drug resistance in dialogue: pre-clinical and clinical evidence. Cancer Lett. 2023;570: 216307.

Article  CAS  PubMed  Google Scholar 

Donald G, Hertzer K, Eibl G. Baicalein–an intriguing therapeutic phytochemical in pancreatic cancer. Curr Drug Targets. 2012;13(14):1772–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Li H, Chen F, Luo J, Gu J, Wang H, et al. Baicalin extracted from Huangqin (Radix Scutellariae Baicalensis) induces apoptosis in gastric cancer cells by regulating B cell lymphoma (Bcl-2)/Bcl-2-associated X protein and activating caspase-3 and caspase-9. J Tradit Chin Med. 2017;37(2):229–35.

Article  CAS  PubMed  Google Scholar 

Wang J, Wu Z, Peng J, You F, Ren Y, Li X, et al. Multiple roles of baicalin and baicalein in the regulation of colorectal cancer. Front Pharmacol. 2024;15:1264418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tuli HS, Aggarwal V, Kaur J, Aggarwal D, Parashar G, Parashar NC, et al. Baicalein: a metabolite with promising antineoplastic activity. Life Sci. 2020;259: 118183.

Article  CAS  PubMed  Google Scholar 

Kalapos-Kovacs B, Magda B, Jani M, Fekete Z, Szabo PT, Antal I, et al. Multiple ABC transporters efflux baicalin. Phytother Res. 2015;29(12):1987–90.

Article  CAS  PubMed  Google Scholar 

Wei Y, Guo J, Zheng X, Wu J, Zhou Y, Yu Y, et al. Preparation, pharmacokinetics and biodistribution of baicalin-loaded liposomes. Int J Nanomedicine. 2014;9:3623–30.

CAS  PubMed  PubMed Central  Google Scholar 

Yang M, Li X, Li H, Zhang X, Liu X, Song Y. Baicalein inhibits RLS3-induced ferroptosis in melanocytes. Biochem Biophys Res Commun. 2021;561:65–72.

Article  CAS  PubMed  Google Scholar 

Wang R, Wang C, Lu L, Yuan F, He F. Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: a comprehensive review with future perspectives. Pharmacol Res. 2024;199: 107032.

Article  CAS  PubMed  Google Scholar 

Li X, Ai S, Lu X, Liu S, Guan W. Nanotechnology-based strategies for gastric cancer imaging and treatment. RSC Adv. 2021;11(56):35392–407.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Noh K, Kang Y, Nepal MR, Jeong KS, Oh DG, Kang MJ, et al. Role of intestinal microbiota in baicalin-induced drug interaction and its pharmacokinetics. Molecules. 2016;21(3):337.

Article  PubMed  PubMed Central  Google Scholar 

Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649–658 e2.

Li H, Li B, Wang X, Zhang H, Wang C, Fan B, et al. Effect of longitudinal changes of cachexia on the efficacy and toxicity of immune checkpoint inhibitors in esophageal squamous cell cancer (ESCC) patients. Nutrition. 2024;124: 112462.

Article  CAS  PubMed  Google Scholar 

Pal D, Tyagi A, Chandrasekaran B, Alattasi H, Ankem MK, Sharma AK, et al. Suppression of Notch1 and AKT mediated epithelial to mesenchymal transition by Verrucarin J in metastatic colon cancer. Cell Death Dis. 2018;9(8):798.

Article  PubMed  PubMed Central  Google Scholar 

Moselhy J, Srinivasan S, Ankem MK, Damodaran C. Natural products that target cancer stem cells. Anticancer Res. 2015;35(11):5773–88.

CAS  PubMed  PubMed Central  Google Scholar 

Pal D, Kolluru V, Chandrasekaran B, Baby BV, Aman M, Suman S, et al. Targeting aberrant expression of Notch-1 in ALDH(+) cancer stem cells in breast cancer. Mol Carcinog. 2017;56(3):1127–36.

Article  CAS  PubMed  Google Scholar 

Chaudhary M, Sharma P, Mukherjee TK. Applications of CRISPR/Cas technology against drug-resistant lung cancers: an update. Mol Biol Rep. 2022;49(12):11491–502.

Article  CAS  PubMed  Google Scholar 

Chaudhary M, Mukherjee TK, Singh R, Gupta M, Goyal S, Singhal P, et al. CRISPR/Cas technology for improving nutritional values in the agricultural sector: an update. Mol Biol Rep. 2022;49(7):7101–10.

Article  CAS  PubMed  Google Scholar 

Zhang HB, Lu P, Guo QY, Zhang ZH, Meng XY. Baicalein induces apoptosis in esophageal squamous cell carcinoma cells through modulation of the PI3K/Akt pathway. Oncol Lett. 2013;5(2):722–8.

Article  CAS  PubMed  Google Scholar 

Guo D, Jin J, Liu J, Wang Y, Li D, He Y. Baicalein inhibits the progression and promotes radiosensitivity of esophageal squamous cell carcinoma by targeting HIF-1A. Drug Des Devel Ther. 2022;16:2423–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Won SY, Park JJ, Shin EY, Kim EG. PAK4 signaling in health and disease: defining the PAK4-CREB axis. Exp Mol Med. 2019;51(2):1–9.

Article  CAS  PubMed  Google Scholar 

Liu Y, Sun X, Liu J, Liu W, Jin J, Liu Y. Baicalein inhibits the growth of transplanted esophageal cancer in mice and the effect on the expression of PAK4. Bull Exp Biol Med. 2023;174(4):478–81.

Article  CAS  PubMed  Google Scholar 

Pal D, Kashyap D, Sharma A, Sharma U, Sarma P, Singh A, et al. Withaferin A: the potent anti-cancer agent from Ashwagandha. Minerva Biotechnol Biomol Res 2024;36:118–29. https://doi.org/10.23736/S2724-542X.24.03124-9

Article  Google Scholar 

de Moraes FCA, de Oliveira Rodrigues ALS, Priantti JN, Limachi-Choque J, Burbano RMR. Efficacy and safety of anti-EGFR therapy rechallenge in metastatic colorectal cancer: a systematic review and meta-analysis. J Gastrointest Cancer. 2024;56(1):9.

Article  PubMed  Google Scholar 

Boileve A, Smolenschi C, Lambert A, Boige V, Delaye M, Camilleri GM, et al. KRAS, a new target for precision medicine in colorectal cancer? Cancers (Basel). 2024;16(20).

Lopez AR, Jorgensen MH, Havelund JF, Arendrup FS, Kolapalli SP, Nielsen TM, et al. Autophagy-mediated control of ribosome homeostasis in oncogene-induced senescence. Cell Rep. 2023;42(11): 113381.

Article  CAS  PubMed  Google Scholar 

Liu XL, Ding J, Meng LH. Oncogene-induced senescence: a double edged sword in cancer. Acta Pharmacol Sin. 2018;39(10):1553–8.

Article  CAS